Approval In Principle

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

The European Commission (EC), the European Union (EU) antitrust body, approved the merger between Korean Air Lines Co. and Asiana Airlines Inc. on N...

South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...

South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...

South Korean chemical and food ingredient manufacturer Samyang Corp. said on Wednesday that it has become the first allulose producer to secure appr...

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...

SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...

South Korea has decided to extend the range of missiles for export to 500 kilometers from the current 300 km after accepting requests to do so from ...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

South Korean confectionery giant Lotte Wellfood Co. will merge its Indian subsidiaries — Lotte India Co. and Havmor Ice Cream Pvt — to b...

Doosan Group’s announcement of a merger between Doosan Robotics Inc. and Doosan Bobcat Inc. has met with strong criticism from investors and p...

South Korea’s antitrust body has given a conditional nod to leading domestic shipyard HD Korea Shipbuilding & Offshore Engineering Co.'s (...

Hanwha Aerospace Co., South Korea’s top defense manufacturer, and Doosan Enerbility Co., a major local power plant builder, are set to develop...

Solus Advanced Materials, a South Korean copper foil supplier, will provide copper foil for AI accelerators to Nvidia, a leading company in artifici...

The Kosdaq market under the Korea Exchange said on Wednesday it has canceled its preliminary approval for InnoGrid Co.’s initial public offeri...

South Korea's Hanwha Ocean Co. said on Thursday it received Approval in Principle (AIP) from classification society ABS for a 40,000 cubic meter liq...

Korean Air Lines Co., South Korea’s No. 1 full-service carrier, expects to gain full approval from the US government by the end of October to ...

HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...

South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...

Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, is spinning off its non-core units to focus on defense and aerospace b...